Pharma Patent Cliff
Drug companies optimize for high-margin chronic conditions, not cures.
"A cure is a one-time revenue event. A treatment is an annuity."
What is Pharma Patent Cliff? Drug companies optimize for high-margin chronic conditions, not cures. Innovation portfolios shaped by IP economics, not by patient need.
More R&D on chronic management than on disease elimination.
Innovation portfolios shaped by IP economics, not by patient need.
Public-private hybrid funding for under-incentivized disease classes.
Flip the incentive. Watch the side-effect move.
Drug companies optimize for high-margin chronic conditions, not cures. Caught in the wild: More R&D on chronic management than on disease elimination.
In the room: Innovation portfolios shaped by IP economics, not by patient need.
Counter-move from the Atlas: Public-private hybrid funding for under-incentivized disease classes.
Pick a reaction to Pharma Patent Cliff
One tap. We'll point you at the most useful next surface based on how this hits.
The full taxonomy entry
Every concept in the Atlas uses the same structure — so Pharma Patent Cliff can be compared, recombined, and cited like an element on a periodic table.
- Business
- Leadership
- Government
- Healthcare
- Education
- Sales
- Marketing
- AI
- Negotiation
- Media
- Public Policy
- Relationships
- Where in our org would Pharma Patent Cliff most often show up unnoticed?
- Which metric, ritual, or contract clause quietly rewards Pharma Patent Cliff?
- If we removed every payoff for Pharma Patent Cliff, what behavior would replace it?
- Who benefits when Pharma Patent Cliff persists — and who pays the cost?
- People defend the status quo using the language of pharma patent cliff.
- Decisions cluster around the easiest narrative rather than the strongest evidence.
- New data changes the slide deck but not the decision.
- Anyone naming the pattern is treated as the problem.
Every Atlas entry is a node in a knowledge graph. See the related rail below to follow the connections.
See Pharma Patent Cliff through 4 lenses
Each layer of the Incentives OS reframes this concept with its own thinkers, vocabulary, and diagnostic question.
- Layer 11Economics & Mechanism Design
Who pays, who is paid, and what does the price signal hide?
- Layer 14Innovation
What job is the user really hiring this for?
- Layer 18Temporal Models
What happens if this incentive compounds for ten years?
- Layer 19Human Needs & Meaning
Which basic human need is being met — or starved — by this design?
Do you actually know Pharma Patent Cliff?
Three quick questions. Result is saved into your review streak — come back when the term is due to lock it in.
Which best describes Pharma Patent Cliff?
Worked example, counter-example & concept map
On-demand AI analysis grounded in the Lab's research. Cached on your device after first run.
When you encounter Pharma Patent Cliff, your amygdala tags it as threat before your reasoning brain even knows what happened — and threat wins the first move.
Threat detection, fear, social pain, loss aversion, fast emotional tagging. Loss feels roughly twice as bad as equivalent gain feels good. Social rejection lights up the same circuits as physical pain.
See Amygdala in the Brain Atlas →Picked for you, from the Atlas
Ranked by shared learning paths, overlapping chips, and what you've saved.
Productivity targets compress visits, raising misdiagnosis and burnout.
A federal mandate intended to lower drug costs for the poor became a profit engine for hospitals and contract pharmacies.
Liability exposure pushes clinicians to order tests for legal protection rather than clinical need.
Federal reimbursement rules incentivize cycling seniors through hospitalizations to upgrade billing categories.
Paying providers per procedure rewards more procedures, not better outcomes.
Systems paid per filled bed have weak incentives to invest in prevention or community health.
Send the card, not just the link
A pre-rendered social card with the title, eyebrow, and URL. Copy the link, post it anywhere, or download the SVG for slides.
More definitions to follow
Every term in the Atlas connects to a dozen others. Pick any of these and see where it takes you.
Binding yourself now to avoid future temptation.
Teams built around AI from day one vs. teams adding it to existing workflows.
Membership in a group is a baseline human need.
Working memory has limits.
Endless choice and swipe loops reduce commitment and increase dissatisfaction.
Systems maintain stability by self-regulating around a setpoint.
Any small cost — clicks, forms, thought — that shifts behavior.
Accumulated workarounds for misaligned incentives that compound like technical debt.
When all you have is a hammer, everything looks like a nail.
20% of your activity produces 80% of the result. Find it. Cut the rest.
Assume the opposite of what you want to prove. Derive a contradiction. The opposite must be false.
We look to others to decide what's correct.